A unique bond that provides investors with both financial returns and the personal satisfaction of helping children in poor countries through immunization will tap the Japanese market again next month.

New “vaccine bonds” targeted at individual investors will go on sale Feb. 9, following the first offering in Tokyo last March, with issuers confident the product will prove popular even in these turbulent times due to their AAA rating and strong interest among doctors.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.